BPG is committed to discovery and dissemination of knowledge
Featured Articles
5/24/2023 10:28:01 AM | Browse: 400 | Download: 1391
Publication Name World Journal of Hepatology
Manuscript ID 83748
Country Italy
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Current guidelines for diagnosis and management of hepatic involvement in hereditary hemorrhagic teleangiectasia
Manuscript Source Invited Manuscript
All Author List Luca Ielasi, Matteo Tonnini, Fabio Piscaglia and Ilaria Serio
Funding Agency and Grant Number
Corresponding Author Luca Ielasi, MD, Doctor, Doctor, Department of Medical and Surgical Sciences, University of Bologna, Via Albertoni, 15, Bologna 40138, Italy. luca.ielasi.kr@gmail.com
Key Words Hereditary hemorrhagic teleangiectasia; Rendu-Osler-Weber syndrome; Hepatic vascular malformations; Liver
Core Tip Hereditary hemorrhagic teleangiectasia (HHT) is the most common cause of hepatic vascular malformation in adults. Although liver involvement is common in HHT, most patients do not present any hepatic-related symptoms. Unfortunately, some patients have severe forms of disease with refractory medical conditions related to the hepatic vascular malformations. For those patients the only definitive treatment available at present is liver transplantation.
Publish Date 2023-05-24 09:31
Citation Ielasi L, Tonnini M, Piscaglia F, Serio I. Current guidelines for diagnosis and management of hepatic involvement in hereditary hemorrhagic teleangiectasia. World J Hepatol 2023; 15(5): 675-687
URL https://www.wjgnet.com/1948-5182/full/v15/i5/675.htm
DOI https://dx.doi.org/10.4254/wjh.v15.i5.675
Full Article (PDF) WJH-15-675-with-cover.pdf
Full Article (Word) WJH-15-675.docx